Plasma levels of soluble CD30 are increased in children with chronic renal failure and with primary growth deficiency and decrease during treatment with recombination human growth hormone

Nephrology Dialysis Transplantation

Volumn 16, Issue 9, 2001, Pages 1807-1813

  Barbano, Giancarlo ^a   Cappa, Francesca ^a   Prigione, Ignazia ^a   Pistoia, Vito ^a   Cohen, Amnon ^a   Chiesa, Sabrina ^a   Gusmano, Rosanna ^a   Perfumo, Francesco ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

CD30; Chronic renal failure; Growth hormone therapy; Primary growth hormone deficiency; T helper 2 (Th2) lymphocytes

Indexed keywords

CD30 ANTIGEN; HUMAN GROWTH HORMONE;

ADOLESCENT; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; BLOOD LEVEL; CHILDHOOD DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HORMONE ACTION; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TH1 CELL; TH2 CELL;

EID: 0034844260     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.9.1807     Document Type: Article

References (23)

1. The relationship between the immune and endocrine systems
2. Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance
3. Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis
4. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells
5. CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells
6. Hodgkin's disease: A tumor with disturbed immunological pathways
7. Circulating levels of soluble CD30, a marker of cells producing Th2-type cytocines, are increased in patients with systemic lupus eritematosus and correlate with the disease activity
8. Immunologic perspectives in chronic renal failure
9. In vivo T cell preactivation in chronic uremic hemodialyzed and non-hemodialyzed patients
10. Growth hormone therapy in adults and children
11. Effect of growth hormone treatment on the adult height of children with chronic renal failure
12. Recombinant human growth hormone treatment in short children with chronic renal disease, before transplantation or with functioning renal transplants; an interim report on five european studies
13. Treatment of growth failure in children after renal transplantation
14. The effect of recombinant growth hormone on responses to alloantigens in the pediatric transplant patient
15. Growth hormone (GH) secretion from human lymphocytes is up-regulated by GH, but not affected by Insulin-Like Growth Factor-I
16. Recombinant human growth hormone augments responses in the mixed leukocyte culture
17. Growth hormone and markers of immune function in children with renal transplants
18. The roles of prolactin, growth hormone, insulin-like growth factor-I and thyroid hormones in lymphocyte development and function: Insights from genetic models of hormone receptor deficiency
19. Increased mortality associated with growth hormone treatment in critically ill adults
20. CD30 expression does not discriminate between human Th1- and Th2-type T cells
21. Soluble CD30, dehydroepiandrosterone sulfate and dehydroepiandrosterone in atopic and non atopic children
22. Growth hormone therapy in critically ill patients
23. The somatogenic hormones and insulin-like growth factor-1: Stimulators of lymphopoiesis and immune function